Does SHBG binding reduce free testosterone, and is rs1799941 linked to higher SHBG?

Physiological testosterone regulation

• High-affinity sequestration: Sex hormone-binding globulin (SHBG) regulates systemic androgen availability by directly binding circulating testosterone with an association constant ($K_a$) of approximately $1.0 \times 10^9 \text{ L/mol}$. This high-affinity interaction physically sequesters 43% to 45% of total circulating testosterone.
• Reduction of active fractions: Under the free hormone hypothesis, only unbound testosterone (1% to 2%) and weakly albumin-bound testosterone (53% to 55%) are biologically active. By driving the chemical equilibrium toward stable, bound complexes, elevated SHBG directly reduces these free and bioavailable fractions, lowering tissue-level androgen exposure.

Genetic influence of rs1799941

• Transcriptional modulation: The rs1799941 (G>A) variant is located in the proximal promoter/5′ untranslated region of the SHBG gene. The minor A allele acts as a functional expression quantitative trait locus (eQTL) that upregulates hepatic transcription and processing of the SHBG protein.
• Quantitative SHBG and hormone shifts: Each copy of the rs1799941 A allele increases circulating SHBG levels by approximately 13% (~4.67 nmol/L, $P = 3.7 \times 10^{-14}$), with AA homozygotes exhibiting 26.9% to 39% higher mean SHBG levels compared to GG homozygotes.
• Impact on total testosterone: Consequently, carriers of the rs1799941 A allele exhibit significantly higher total circulating testosterone levels; however, this increase is primarily a feedback response to, and sequestered by, the elevated SHBG pool.

Bottom line

• The rs1799941 A allele is robustly associated with up to a 39% increase in circulating SHBG levels. This genetic elevation drives high-affinity sequestration of circulating testosterone, ultimately restricting the free and bioavailable fractions that are physiologically active at target tissues.